Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    BG12 compound

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 335Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ZIM Lab receives marketing authorization for Dimethyl Fumarate
    ZIM Lab receives marketing authorization for Dimethyl Fumarate

    20 Mar 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/zim-laboratories-receives-marketing-authorization-for-dimethyl-fumarate-in-portugal-16916

    INDPHARMAPOST
    20 Mar 2025
    Share Share
    Torrent`s Generics Dimethyl Fumarate Receives Approval in US
    Torrent`s Generics Dimethyl Fumarate Receives Approval in US

    06 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210390

    FDA
    06 Jan 2025
    Share Share
    Biogen Sued Over Alleged PBM Kickbacks For Tecfidera
    Biogen Sued Over Alleged PBM Kickbacks For Tecfidera

    21 Aug 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/biogen-sued-alleged-pbm-kickbacks-scheme-boost-tecfidera-sales-wake-generic-competition

    FIERCE PHARMA
    21 Aug 2024
    Share Share
    Macleods Pharms Generic Dimethyl Fumarate Receives Approval in US
    Macleods Pharms Generic Dimethyl Fumarate Receives Approval in US

    26 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210377

    FDA
    26 Jun 2024
    Share Share
    Biogen notches another Tecfidera patent win in Europe
    Biogen notches another Tecfidera patent win in Europe

    20 Dec 2023

    // Fraiser Kansteiner FIERCE PHARMA

    https://www.fiercepharma.com/pharma/biogen-notches-another-tecfidera-patent-win-europe-ec-blocks-generics-mylan-teva-and-more

    Fraiser Kansteiner FIERCE PHARMA
    20 Dec 2023
    Share Share
    EC revokes all centrally granted generic marketing permissions for DMF
    EC revokes all centrally granted generic marketing permissions for DMF

    20 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/european-commission-revokes-all-centrally-granted-generic-marketing-permissions-for-dimethyl-fumarate-dmf-including-dimethyl-fumarate-neuraxpharm-302020027.html

    PR NEWSWIRE
    20 Dec 2023
    Share Share